Skip to main content
. 2017 May 2;42(7):1894–1903. doi: 10.1007/s11064-017-2275-z

Fig. 2.

Fig. 2

The Anticonvulsant Screening Program (ASP) has tested 32,000 compounds from 38 countries, representing participants from academia, industry, and government sectors